Venous Thromboembolism Clinical Trials

80 recruitingLast updated: June 17, 2026

There are 80 actively recruiting venous thromboembolism clinical trials across 44 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2, Early Phase 1, Phase 1. Top locations include Boston, Massachusetts, United States, Ottawa, Ontario, Canada, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


Venous Thromboembolism Trials at a Glance

80 actively recruiting trials for venous thromboembolism are listed on ClinicalTrialsFinder across 6 cities in 44 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Boston, Ottawa, and Montreal. Lead sponsors running venous thromboembolism studies include Ottawa Hospital Research Institute, University Hospital, Brest, and Regeneron Pharmaceuticals.

Browse venous thromboembolism trials by phase

Treatments under study

About Venous Thromboembolism Clinical Trials

Looking for clinical trials for Venous Thromboembolism? There are currently 60 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous Thromboembolism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous Thromboembolism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 80 trials

Recruiting
Not Applicable

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)

Venous ThromboembolismPulmonary Embolism
University Hospital, Brest665 enrolled13 locationsNCT06372730
Recruiting
Not Applicable

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Quality of Life (QOL)Exercise TherapyAnxiety Depression+7 more
Insel Gruppe AG, University Hospital Bern160 enrolled6 locationsNCT07143539
Recruiting
Phase 4

Statins to Prevent Cancer Associated Blood Clots

CancerVenous ThromboembolismCardiovascular Events
Brigham and Women's Hospital4,000 enrolled2 locationsNCT07303816
Recruiting
Phase 4

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Venous Thromboembolism (VTE)Post-partum Women
University Hospital, Brest2,400 enrolled18 locationsNCT06845423
Recruiting
Not Applicable

Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)

Venous Thromboembolism (VTE)
University Hospital, Brest10 enrolled1 locationNCT06057844
Recruiting
Phase 4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Venous ThromboembolismVaricose Veins
Imperial College London3,175 enrolled1 locationNCT05735639
Recruiting
Phase 3

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled19 locationsNCT07213778
Recruiting
Not Applicable

Variations in the Hemostatic System Induced by a Standardized Walking Test

Venous Thromboembolism
Centre Hospitalier Universitaire de Nīmes94 enrolled1 locationNCT06418633
Recruiting
Not Applicable

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Deep Venous ThrombosisVenous ThromboembolismPost Thrombotic Syndrome
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting
Phase 3

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals1,600 enrolled2 locationsNCT07493304
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

Cancer-related Venous Thromboembolism
M.D. Anderson Cancer Center260 enrolled4 locationsNCT03407469
Recruiting

Aspiration Thrombectomy Using the Symphony or Prodigy System

Venous ThromboembolismArterial ThromboembolismPulmonary Embolism
Imperative Care, Inc.750 enrolled2 locationsNCT07350499
Recruiting

Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study

CancerVenous Thromboembolism
University of Dublin, Trinity College380 enrolled3 locationsNCT07196020
Recruiting
Not Applicable

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Deep Venous ThrombosisVenous Thromboembolism
Memorial Sloan Kettering Cancer Center259 enrolled8 locationsNCT07399977
Recruiting
Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled44 locationsNCT07015905
Recruiting

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital2,400 enrolled5 locationsNCT06950697
Recruiting

Evaluation of the SCALED (SCaling AcceptabLE cDs)

Traumatic Brain InjuryVenous Thromboembolism
University of Minnesota15,000 enrolled1 locationNCT05628207
Recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
Cook Research Incorporated82 enrolled7 locationsNCT05881798
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516